Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012

High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856

MODELS OF AMYLOID SEEDING IN ALZHEIMER'S DISEASE AND SCRAPIE: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins

Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324

Immunotherapy as treatment for Alzheimer’s disease

Hawkes, C. A., & McLaurin, J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1535 · Cited by 33

Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy

Rossi, D., Gruart, A., Contreras-Murillo, G., Muhaisen, A., Ávila, J., Delgado-García, J. M., Pujadas, L., & Soriano, E. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101743 · Cited by 30

Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress

Pensalfini, A., Cecchi, C., Zampagni, M., Becatti, M., Favilli, F., Paoli, P., Catarzi, S., Bagnoli, S., Nacmias, B., Sorbi, S., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.025 · Cited by 32

Gastrodin Suppresses the Amyloidβ-Induced Increase of Spontaneous Discharge in the Entorhinal Cortex of Rats

Chen, P.-Z., Jiang, H., Wen, B., Ren, S., Chen, Y., Ji, W.-G., Hu, B., Zhang, J., Xu, F., & Zhu, Z.-R. (2014) · Neural Plasticity · doi:10.1155/2014/320937 · Cited by 32

Protein Aggregation in Alzheimers Disease and Other Neoropathological Disorders

Dimakopoulos, A. C. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772795 · Cited by 33

Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Aβ1–6: Toward safer and effective vaccines against Alzheimer’s disease

Kim, H., Maxwell, J. A., Kong, F.-K., Tang, D.-C. C., & Fukuchi, K.-I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.044 · Cited by 32

Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine

Marciani, D. J. (2019) · Research · doi:10.34133/2019/5341375 · Cited by 33

Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity

Desai, A. A., Smith, M. D., Zhang, Y., Makowski, E. K., Gerson, J. E., Ionescu, E., Starr, C. G., Zupancic, J. M., Moore, S. J., Sutter, A. B., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100508 · Cited by 31

A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ

O’Nuallain, B., Klyubin, I. V., Donald, J. M. M., Foster, J. S., Welzel, A. T., Barry, A. E., Dykoski, R. K., Cleary, J. P., Gebbink, M. F. B. G., Rowan, M. J., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07389.x · Cited by 33

Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine

Kabir, M. T., Uddin, M. S., Mathew, B., Das, P. K., Perveen, A., & Ashraf, G. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200422105156 · Cited by 32

Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration

Narendran, S., Pereira, F., Yerramothu, P., Apicella, I., Wang, S.-B., Ambati, K., Hirahara, S., Kim, Y., Ambati, M., Ambati, V. L., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00537-z · Cited by 31

Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins

Lambert, M., Velasco, P., Viola, K., & Klein, W. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601876 · Cited by 29

The Modulating Effect of Mechanical Changes in Lipid Bilayers Caused by ApoE-Containing Lipoproteins on Aβ Induced Membrane Disruption

Legleiter, J. A., Fryer, J. D., Holtzman, D. M., & Kowalewski, T. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2000475 · Cited by 28

Targeting Pathological Amyloid Aggregates with Conformation-Sensitive Antibodies

Bigi, A., Loffredo, G., Cascella, R., & Cecchi, C. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109093848 · Cited by 29

α-synuclein-assisted oligomerization of β-amyloid (1–42)

Chau, E., & Kim, J. R. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109120 · Cited by 30

Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?

Rommy von Bernhardi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1248 · Cited by 28

Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers

Ishizuka, Y., Shimizu, H., Takagi, E., Kato, M., Yamagata, H., Mikuni, M., & Shirao, T. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.07.005 · Cited by 26

Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity

Limegrover, C. S., LeVine, H., Izzo, N. J., Yurko, R., Mozzoni, K., Rehak, C., Sadlek, K., Safferstein, H., & Catalano, S. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15212 · Cited by 24

Estrogen-induced signaling attenuates soluble Aβ peptide-mediated dysfunction of pathways in synaptic plasticity

Logan, S. M., Sarkar, S. N., Zhang, Z., & Simpkins, J. W. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.038 · Cited by 27

Elucidating Molecular Mass and Shape of a Neurotoxic Aβ Oligomer

Sebollela, A. S., Mustata, G.-M., Luo, K., Velasco, P. T., Viola, K. L., Cline, E. N., Shekhawat, G. S., Wilcox, K. C., Dravid, V. P., & Klein, W. L. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500156r · Cited by 25

The Effect of Membranes on the In Vitro Fibrillation of an Amyloidogenic Light-Chain Variable-Domain SMA

Meng, X., Fink, A. L., & Uversky, V. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.062 · Cited by 25

Small Molecules and Alzheimer’s Disease: Misfolding, Metabolism and Imaging

Patel, V., Zhang, X., Tautiva, N., Nyabera, A., Owa, O., Baidya, M., Sung, H., Taunk, P., Abdollahi, S., Charles, S., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150504145646 · Cited by 25

Alzheimer vaccine: amyloid‐β on trial

Robinson, S. R., Bishop, G. M., & Münch, G. W. (2003) · BioEssays · doi:10.1002/bies.10236 · Cited by 25

Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree

Wen, J., Fang, F., Guo, S., Zhang, Y., Peng, X.-L., Sun, W., Wei, X., He, J., & Hung, T. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-1015-9 · Cited by 25

Per-6-substituted β-cyclodextrin libraries inhibit formation of β-amyloid-peptide (Aβ)-derived, soluble oligomers

Yu, J., Bakhos, L., Chang, L., Holterman, M., Klein, W. L., & Venton, D. L. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0010-x · Cited by 24

Targeting soluble amyloid-beta oligomers with a novel nanobody

Haynes, J. R., Whitmore, C. A., Behof, W. J., Landman, C. A., Ong, H. H., Feld, A. P., Suero, I. C., Greer, C. B., Gore, J. C., Wijesinghe, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-66970-6 · Cited by 23

Detection of Soluble Amyloid‐β Oligomers and Insoluble High‐Molecular‐Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer′s Disease

Funke, S. A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/151645 · Cited by 23

Molecules that Disrupt Memory Circuits in Alzheimer’s Disease: The Attack on Synapses by Aβ Oligomers (ADDLs)

Klein, W. L., Lacor, P. N., Felice, F. G. D., & Ferreira, S. T. (2007) · Research and perspectives in neurosciences · doi:10.1007/978-3-540-45702-2_11 · Cited by 23

The conformational epitope for a new Aβ42 protofibril‐selective antibody partially overlaps with the peptide N‐terminal region

Colvin, B. A., Rogers, V. A., Kulas, J. A., Ridgway, E. A., Amtashar, F. S., Combs, C. K., & Nichols, M. R. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14211 · Cited by 21

Functional adlayers on Au electrodes: some recent applications in hydrogen evolution and oxygen reduction

Chattopadhyay, S., Sarkar, A., Chatterjee, S., & Dey, A. (2017) · Journal of Materials Chemistry A · doi:10.1039/c7ta09179f · Cited by 21

An antibody to the β-secretase cleavage site on amyloid-β-protein precursor inhibits amyloid-β production

Thomas, R. S., Liddell, J. E., Murphy, L. S., Pache, D. M., & Kidd, E. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10406 · Cited by 21

Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs

Park, S.-K., Ratia, K. M., Ba, M. A., Valencik, M. L., & Liebman, S. W. (2016) · Microbial Cell · doi:10.15698/mic2016.02.476 · Cited by 21

The initial stage of structural transformation of Aβ42 peptides from the human and mole rat in the presence of Fe2+ and Fe3+: Related to Alzheimer's disease

Vahed, M., Sweeney, A., Shirasawa, H., & Vahed, M. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107128 · Cited by 19

Two Distinct Conformations of Aβ Aggregates on the Surface of Living PC12 Cells

Bateman, D. A., & Chakrabartty, A. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.01.056 · Cited by 19

Adsorption of Amyloid Beta Peptide by Metal–Organic Frameworks

Mensinger, Z. L., Cook, B. L., & Wilson, E. L. (2020) · ACS Omega · doi:10.1021/acsomega.0c04019 · Cited by 19

Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression

Beckett, T. L., Webb, R. L., Niedowicz, D. M., Holler, C. J., Matveev, S., Baig, I., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120655 · Cited by 20

Norovirus P particle: An excellent vaccine platform for antibody production against Alzheimer’s disease

Fu, L., Li, Y., Hu, Y., Yu, B., Zhang, H., Wu, J., Wu, H., Yu, X., & Kong, W. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.09.002 · Cited by 18

A new procedure for amyloid β oligomers preparation enables the unambiguous testing of their effects on cytosolic and mitochondrial Ca 2+ entry and cell death in primary neurons

Caballero, E., Calvo-Rodríguez, M., Gonzalo‐Ruiz, A., Villalobos, C., & Núñez, L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.041 · Cited by 20

Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model

Chuang, W.-H., Chou, Y.-T., Chen, Y.-H., Kuo, T.-H., Liaw, W., Lu, T., Kao, C.-F., & Wang, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00348 · Cited by 17

Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-β in a Fraction of Amyloid-β Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggregates

Venkataramani, V., Wirths, O., Budka, H., Härtig, W., Kovács, G. G., & Bayer, T. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111379 · Cited by 17

Kalirin‐7 prevents dendritic spine dysgenesis induced by amyloid beta‐derived oligomers

Xie, Z., Shapiro, L. P., Cahill, M. E., Russell, T. A., Lacor, P. N., Klein, W. L., & Penzes, P. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14311 · Cited by 16

Syndapin-2 mediated transcytosis of amyloid-β across the blood–brain barrier

Leite, D. M., Seifi, M., Ruiz‐Pérez, L., Nguemo, F., Plomann, M., Swinny, J. D., & Battaglia, G. (2022) · Brain Communications · doi:10.1093/braincomms/fcac039 · Cited by 16

Monosialotetrahexosylganglioside Promotes Early Aβ42 Oligomer Formation and Maintenance

Zhang, D. Y., Wang, J., Fleeman, R. M., Kuhn, M. K., Swulius, M. T., Proctor, E. A., & Dokholyan, N. V. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00221 · Cited by 14

Oligomer-targeting with a conformational antibody fragment promotes toxicity in Aβ-expressing flies

Wacker, J., Rönicke, R., Westermann, M., Wulff, M., Reymann, K. G., Dobson, C. M., Horn, U., Crowther, D. C., Luheshi, L. M., & Fändrich, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-43 · Cited by 14

A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity

Xue, C., Lee, Y. K., Tran, J., Chang, D., & Guo, Z. (2017) · Royal Society Open Science · doi:10.1098/rsos.170325 · Cited by 13

Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus

Forner, S., Martini, A. C., Prieto, G. A., Dang, C. T., Rodríguez‐Ortiz, C. J., Reyes‐Ruiz, J. M., Trujillo‐Estrada, L., da Cunha, C., Andrews, E. J., Phan, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52324-0 · Cited by 15

Preparation and in vitro activity of single chain antibodies against Alzheimer's disease

Fu, L., Zhang, Y., Zhang, X., Tian, W., Zhang, W., Jia, Y. X., & Zhang, L. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.07.009 · Cited by 13

Altered auditory-evoked potentials in mice carrying mutated human amyloid precursor protein and presenilin-1 transgenes

Wang, J., Ikonen, S., Gurevicius, K., Groen, T. V., & Tanila, H. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00714-5 · Cited by 13

Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease

Kou, J., Song, M., Pattanayak, A., Lim, J. E., Yang, J., Cao, D., Li, L., & Fukuchi, K. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.01.008 · Cited by 12

Riluzole prevents soluble Aβ1–42oligomers-induced perturbation of spontaneous discharge in the hippocampal CA1 region of rats

Ren, S., Shao, H., Ji, W.-G., Jiang, H., Xu, F., Chen, P.-Z., Mi, Z., Wen, B., Zhu, G.-X., & Zhu, Z.-R. (2014) · Amyloid · doi:10.3109/13506129.2014.990558 · Cited by 12

Disease Modifying Therapies for Alzheimer's Disease Targeting AβOligomers: Implications for Therapeutic Mechanisms

Matsubara, E., Takamura, A., Okamoto, Y., Oono, H., Nakata, T., Wakasaya, Y., Kawarabayashi, T., & Shoji, M. (2013) · BioMed Research International · doi:10.1155/2013/984041 · Cited by 12

A novel Aβ epitope vaccine based on bacterium-like particle against Alzheimer’s disease

Fu, L., Guo, Y., Sun, Y., Dong, Y., Wu, J., Yu, B., Zhang, H., Yu, X., Wu, H., & Kong, W. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.07.019 · Cited by 12

Imaging amyloid β peptide oligomeric particles in solution

Dong, J., Apkarian, R. P., & Lynn, D. G. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.052 · Cited by 12

A Computational Positron Emission Tomography Simulation Model for Imaging ?-Amyloid in Mice

Simmons, M. K., Manjeshwar, R. M., Agdeppa, E. D., Mattheyses, R. M., Kiehl, T. R., & Montalto, M. (2004) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0952-9 · Cited by 11

A universal TANGO?

Pande, V. S. (2004) · Nature Biotechnology · doi:10.1038/nbt1004-1240 · Cited by 12

Quantitative Attribution of the Protective Effects of Aminosterols against Protein Aggregates to Their Chemical Structures and Ability to Modulate Biological Membranes

Errico, S., Lucchesi, G., Odino, D., Osman, E. Y., Cascella, R., Neri, L., Capitini, C., Calamai, M., Bemporad, F., Cecchi, C., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00182 · Cited by 12

Molecular Mechanisms of Protein Misfolding

Breydo, L., & Uversky, V. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00001-8 · Cited by 11

Cytotoxic Intermediates in the Fibrillation Pathway: Aβ Oligomers in Alzheimer’s Disease as a Case Study

Klein, W. L. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_4 · Cited by 11

Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro

Cattepoel, S., Schaub, A., Ender, M., Gaida, A., Kropf, A., Guggisberg, U., Nolte, M. W., Fabri, L., Adlard, P. A., Finkelstein, D. I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063162 · Cited by 11

Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer’s disease progression

Sánchez-García, M. A., Lara-Ureña, N., March‐Díaz, R., Luis, C. O. S., Quiñones-Cañete, S., Mora-Romero, B., Cabello-Rivera, D., Cabello-Rivera, D., Romero‐Molina, C., Romero‐Molina, C., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2244 · Cited by 10

Neuronal Differentiation of Human Mesenchymal Stromal Cells Increases their Resistance to Aβ42 Aggregate Toxicity

Cecchi, C., Evangelisti, E., Cascella, R., Zampagni, M., Benvenuti, S., Luciani, P., Deledda, C., Cellai, I., Wright, D., Saccardi, R., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110590 · Cited by 10

Anti‐amyloid precursor protein immunoglobulins inhibit amyloid‐β production by steric hindrance

Thomas, R. S., Liddell, J. E., & Kidd, E. J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07942.x · Cited by 10

Antibody therapy for Alzheimer’s disease

Morgan, D. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.1.53 · Cited by 10

Rejecting the Alzheimer's disease vaccine development for the wrong reasons

Marciani, D. J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.012 · Cited by 10

Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype

Lana, E., Gellerbring, A., Jung, S., Nordberg, A. K., Lithner, C. U., & Darreh‐Shori, T. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00176 · Cited by 10

EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure

Jang, C., Barron, D. P., Duo, L., Ma, C., Seabaugh, H., & Guo, Z. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00364 · Cited by 9

Exploring the mechanism of β-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models

Cowan, C. B., Patel, D. A., & Good, T. A. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.02.003 · Cited by 9

Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation

Joshi, P., Chia, S., Yang, X., Perni, M., Gabriel, J. M., Gilmer, M., Limbocker, R., Habchi, J., & Vendruscolo, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00523 · Cited by 8

The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease

Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8

β‐Amyloid immunization approaches for Alzheimer's disease

Imbimbo, B. P. (2002) · Drug Development Research · doi:10.1002/ddr.10070 · Cited by 8

Y10W β(1–40) fluorescence reflects epitope exposure in conformers of Alzheimer’s β-peptide

LeVine, H. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00322-9 · Cited by 8

Oligomerisation differentially affects the acute and chronic actions of amyloid-β in vitro

Innocent, N., Evans, N. A., Hille, C. J., & Wonnacott, S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.003 · Cited by 7

Why Alzheimer’s is a Disease of Memory: Synaptic Targeting by Pathogenic Aβ Oligomers (ADDLs)

Klein, W. L., Felice, F. G. D., Lacor, P. N., Lambert, M. P., & Zhao, W.-Q. (2008) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-76330-7_9 · Cited by 7

β‐Amyloid Therapeutic Strategies for Alzheimer's Disease

Imbimbo, B. P., & Speroni, F. (2005) · Wiley eBooks · doi:10.1002/0471266949.bmc112 · Cited by 6

Capturing Amyloid-β Oligomers by Stirring with Microscaled Iron Oxide Stir Bars into Magnetic Plaques to Reduce Cytotoxicity toward Neuronal Cells

Tsai, Y.-C., Luo, J.-C., Liu, T., Lu, I.-L., Shen, M., Chuang, C., Chern, C., & Chiu, H. (2020) · Nanomaterials · doi:10.3390/nano10071284 · Cited by 6

Beta Amyloid Oligomers with Higher Cytotoxicity have Higher Sidechain Dynamics

Yeh, C., Chang, H., Hsu, W., Huang, S., Wu, M., Tu, L., Lee, M., & Chan, J. C. C. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202301879 · Cited by 6

Aβ Oligomers-Induced Toxicity is Attenuated in Cells Cultured with NbActiv4™ Medium

Zhou, Y., & Klein, W. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9318-7 · Cited by 6

Specific and efficient anti-Aβ42 antibodies induced by sixteen tandem repeats of Aβ9

Cui, L., Huang, X., Wang, J., & Zhang, Y. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.004 · Cited by 6

Soluble Prion Peptide 107–120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer’s Disease

Boroujeni, E. R., Hosseini, S. M., Fani, G., Cecchi, C., & Chiti, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197273 · Cited by 7

Oligomerization and toxicity of Aβ fusion proteins

Caine, J. M., Bharadwaj, P. R., Sankovich, S. E., Ciccotosto, G. D., Streltsov, V. A., & Varghese, J. N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.029 · Cited by 6

Influence of Cr Adhesion Layer on Detection of Amyloid-Derived Diffusible Ligands Based on Localized Surface Plasmon Resonance

Zhu, S., Du, C., Fu, Y., Deng, Q., & Shi, L. (2009) · Plasmonics · doi:10.1007/s11468-009-9084-4 · Cited by 6

Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases

Johnson, E. A., Nowar, R., Viola, K. L., Huang, W., Zhou, S., Bicca, M. A., Zhu, W., Kranz, D. L., Klein, W. L., & Silverman, R. B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402117122 · Cited by 5

Lipoprotein Genes and Diet in the Evolution of Human Intelligence and Longevity

Finch, C. E., & Stanford, C. B. (2003) · Springer eBooks · doi:10.1007/978-3-642-59356-7_3 · Cited by 5

Differential binding and activation of caspase‐3 in cultured hippocampal neurons by assembly forms of Aβ1–42

John, P. A. S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21251 · Cited by 5

Magnetic stirring with iron oxide nanospinners accretes neurotoxic Aβ42 oligomers into phagocytic clearable plaques for Alzheimer's disease treatment

Sabu, A., Huang, Y. C., Sharmila, R., Sun, C.-Y., Shen, M.-Y., & Chiu, H. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101213 · Cited by 4

An aminosterol breaks the autocatalytic cycle of Aβ 42 aggregation and protects cell membranes from its soluble aggregates

Fallot, L. B., Pinc, J. R., Buselmeier, J. E., Palchak, J. C., Shroff, S. S., Zang, K., Rinauro, D. J., Bacon, K. M., Nguyen, M. P., Schleck, M. C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417944122 · Cited by 4

Berberine mitigates neurotoxicity of misfolded protein oligomers by interacting with the cell membrane and subsequent internalization, without altering their structure

Errico, S., Fani, G., Gennari, M., Mastricci, A., Neri, L., Odino, D., Canale, C., Relini, A., Vendruscolo, M., Mannini, B., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146398 · Cited by 4

A new class of monoclonal Aβ antibodies selectively targets and triggers deposition of Aβ protofibrils

Grover, S., Pham, T., Jones, A., Pereira, C. S., Maurino, M. V. D., Garrad, E. C., Makoni, N. J., Parks, A., Domalewski, R. J., Riggio, G., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15817 · Cited by 5

Facile generation of drug-like conformational antibodies specific for amyloid fibrils

Desai, A. A., Zupancic, J. M., Trzeciakiewicz, H., Gerson, J. E., Dubois, K. N., Skinner, M. E., Sharkey, L. M., McArthur, N., Ferris, S. P., Bhatt, N. N., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01881-9 · Cited by 4

Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders

Bitan, F. R. A. G. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058525114020014 · Cited by 4

Tau Therapeutics for Alzheimer's Disease : The Promise and the Challenges

Gold, M. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:329 · Cited by 4

Identification of amyloid antibodies for Alzheimer disease – immunotherapy

Huwait, E. A., Baghallab, I., Glabe, C. G., Abulnaja, K. O., Kumosani, T., & Moselhy, S. S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1767147 · Cited by 4

Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrilsPreprint

Desai, A. A., Zupancic, J. M., Trzeciakiewicz, H., Gerson, J. E., Dubois, K. N., Skinner, M. E., Sharkey, L. M., McArthur, N., Ferris, S. P., Bhatt, N. N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.04.547698 · Cited by 4

Aducanumab binds high molecular weight soluble Aβ oligomers and restores intracellular calcium levels

Yu, L., Wang, X., Doan, T. H., Fan, Y., Bussière, T., Bacskai, B. J., & Kastanenka, K. V. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01812-9 · Cited by 3

The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity

Piccialli, I., Greco, F., Roviello, G. N., Sisalli, M. J., Tedeschi, V., Mola, A. D., Borbone, N., Oliviero, G., Feo, V. D., Secondo, A., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115745 · Cited by 3

Reporters of Amyloid Structural Polymorphism

LeVine, H., Nilsson, K. P. R., Nilsson, R., & Hammarström, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00007-9 · Cited by 3

Antibodies Against b-Amyloid Reduce Ab Oligomers, Glycogen Synthase Kinase-3b Activation and s Phosphorylation In Vivo and In Vitro

Ma, Q., Lim, G. P., Harris‐White, M. E., Yang, F., Ambegaokar, S. S., Ubeda, O. J., Glabe, C. G., Teter, B., Frautschy, S. A., & Cole, G. M. (2006) · Cited by 3

Imaging of Amyloid-β Aggregation Using a Novel Quantum dot Nanoprobe and its Advanced Applications

Tokuraku, K., & Ikezu, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00011-0 · Cited by 3

Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo

Cattepoel, S., Gaida, A., Kropf, A., Nolte, M. W., Bolli, R., & Miescher, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161826 · Cited by 3

Physiological factors could enhance amyloid-beta toxicity

Hunya, Á. G. (2013) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1674 · Cited by 3

Monoclonal antibodies that target pathological assemblies of Aβ

Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y., Bigio, E. H., Shaw, P., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04157.x · Cited by 314

Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989

[P4–384]: ANTI‐AβX‐40 ANTIBODIES EXERT NEUROPROTECTIVE EFFECT AGAINST Aβ‐OLIGOMER TOXICITY

Montañés, M., Marcos, I., Canudas, J., Lacosta, A. M., Pesini, P., & Sarasa, M. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2255 · Cited by 1

Anti-Aβ1–11 Antibody Binds to Different β-Amyloid Species, Inhibits Fibril Formation, and Disaggregates Preformed Fibrils but Not the Most Toxic Oligomers

Mamikonyan, G., Necula, M., Mkrtichyan, M., Ghochikyan, A., Petrushina, I., Movsesyan, N., Mina, E. W., Kiyatkin, A. B., Glabe, C. G., Cribbs, D. H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700088200 · Cited by 95

Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice

Mulder, C. K., Dong, Y., Brugghe, H. F., Timmermans, H., Tilstra, W., Westdijk, J., van Riet, E., STEEG, H. V., Hoogerhout, P., & Eisel, U. L. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151136 · Cited by 7